Senzar Asset Management LLC raised its stake in Mylan N.V. (NASDAQ:MYL) by 318.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 907,100 shares of the company’s stock after buying an additional 690,400 shares during the quarter. Mylan N.V. comprises approximately 8.7% of Senzar Asset Management LLC’s investment portfolio, making the stock its 3rd biggest holding. Senzar Asset Management LLC owned 0.17% of Mylan N.V. worth $35,214,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Wellington Management Group LLP lifted its stake in Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock valued at $1,808,088,000 after buying an additional 1,165,852 shares in the last quarter. BlackRock Inc. lifted its stake in Mylan N.V. by 4.5% in the second quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock valued at $1,575,089,000 after buying an additional 1,751,515 shares in the last quarter. Vanguard Group Inc. lifted its stake in Mylan N.V. by 12.0% in the second quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock valued at $1,276,432,000 after buying an additional 3,531,974 shares in the last quarter. State Street Corp lifted its stake in Mylan N.V. by 1.2% in the first quarter. State Street Corp now owns 20,176,564 shares of the company’s stock valued at $786,700,000 after buying an additional 234,521 shares in the last quarter. Finally, Pzena Investment Management LLC lifted its stake in Mylan N.V. by 69.9% in the second quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock valued at $479,027,000 after buying an additional 5,077,371 shares in the last quarter. 71.97% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Mylan N.V. (MYL) is Senzar Asset Management LLC’s 3rd Largest Position” was first published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/09/24/mylan-n-v-myl-is-senzar-asset-management-llcs-3rd-largest-position.html.

Shares of Mylan N.V. (MYL) traded up 0.19% during trading on Friday, reaching $31.30. 5,203,980 shares of the company were exchanged. The firm’s 50 day moving average price is $31.89 and its 200 day moving average price is $37.29. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. The company has a market capitalization of $16.79 billion, a PE ratio of 25.30 and a beta of 1.31.

Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.08). The company had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.16 earnings per share. Equities research analysts forecast that Mylan N.V. will post $4.52 earnings per share for the current fiscal year.

A number of research analysts have weighed in on MYL shares. UBS AG reaffirmed a “buy” rating and issued a $46.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Citigroup Inc. raised shares of Mylan N.V. from a “neutral” rating to a “buy” rating and lifted their price target for the company from $36.00 to $42.00 in a research note on Wednesday, August 16th. Mizuho reaffirmed a “buy” rating and issued a $37.00 price target (down previously from $53.00) on shares of Mylan N.V. in a research note on Sunday, August 20th. Morgan Stanley cut their price target on shares of Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a research note on Monday, August 7th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $33.00 price target (down previously from $41.00) on shares of Mylan N.V. in a research note on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $42.46.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.